Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 4;19(1):165.
doi: 10.1186/s13018-024-04657-4.

Management of rotator cuff injuries using allogenic platelet-rich plasma

Ashim Gupta  1   2   3   4   5   6 , Filippo Migliorini  7   8   9   10   11 , Nicola Maffulli  12   13   14   5   6
Affiliations

Management of rotator cuff injuries using allogenic platelet-rich plasma

Ashim Gupta et al. J Orthop Surg Res. .

Abstract

Rotator cuff injuries are a major cause of shoulder pain, affecting the quality of life and producing a significant burden on healthcare systems. Conservative management modalities are prioritized, resorting to surgery only when required. The field of regenerative medicine involving the use of biologics, such as platelet-rich plasma (PRP), has evolved and shown potential for managing rotator cuff injuries. Nonetheless, limitations including subpar outcomes have led clinicians to question the efficacy of autologous PRP. To circumvent this, the possibility of utilizing a standardized and well-characterized allogenic PRP for RCI has been explored. In this manuscript, we qualitatively present the evidence from in vitro, pre-clinical, clinical and ongoing studies investigating the applications of allogenic PRP in the context of rotator cuff disorders. Administration of allogenic PRP is safe and potentially efficacious to manage rotator cuff injuries, though more adequately powered randomized controlled trials with longer follow-ups are warranted to further establish the efficacy of allogenic PRP and justify its routine clinical use.

Keywords: Allogenic PRP; PRP; Platelet-rich plasma; Regenerative medicine; Rotator cuff injuries; Rotator cuff tear; Subacromial impingement syndrome.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have any competing interests in this article.

Figures

Fig. 1
Fig. 1
A PRISMA flow diagram outlining the record identification and selection process
See this image and copyright information in PMC

References

    1. Aratikatla A, Maffulli N, Rodriguez HC, Gupta M, Potty AG, Gupta A. Allogenic perinatal tissue for musculoskeletal regenerative medicine applications: a systematic review. Biomedicines. 2022;10(12):3173. doi: 10.3390/biomedicines10123173. - DOI - PMC - PubMed
    1. Lin KM, Wang D, Dines JS. Injection therapies for rotator cuff disease. Orthop Clin North Am. 2018;49(2):231–239. doi: 10.1016/j.ocl.2017.11.010. - DOI - PubMed
    1. Luime JJ, Koes BW, Hendriksen IJ, Burdorf A, Verhagen AP, Miedema HS, Verhaar JA. Prevalence and incidence of shoulder pain in the general population; a systematic review. Scand J Rheumatol. 2004;33(2):73–81. doi: 10.1080/03009740310004667. - DOI - PubMed
    1. Mitchell C, Adebajo A, Hay E, Carr A. Shoulder pain: diagnosis and management in primary care. BMJ. 2005;331(7525):1124–1128. doi: 10.1136/bmj.331.7525.1124. - DOI - PMC - PubMed
    1. Östör AJ, Richards CA, Prevost AT, Speed CA, Hazleman BL. Diagnosis and relation to general health of shoulder disorders presenting to primary care. Rheumatology (Oxford) 2005;44(6):800–5. doi: 10.1093/rheumatology/keh598. - DOI - PubMed